GSK to form consumer healthcare business ‘Haleon’
The proposed demerger is the most significant corporate change for GSK in the last 20 years
The proposed demerger is the most significant corporate change for GSK in the last 20 years
Companies concluded memorandum of understanding that Takeda will continue to provide distribution support for the Moderna COVID-19 vaccines for a transitional period
Dupixent would be the first and only medicine specifically indicated to treat prurigo nodularis in the U.S., if approved
Avillion announces expansion of partnership with AstraZeneca on PT027 and will fund and execute a new Phase 3b study
Data from the three studies formed the basis of the company's application for approval by regulatory agencies
The acquisition is subject to customary closing conditions and necessary regulatory approvals. The financial terms of the transaction are confidential
Perrigo expects to launch Omeprazole Minis later this year
The centre works with active pharmaceutical ingredients (APIs) and can utilize innovative concepts with model APIs
Strategic partnership will develop a digital transformation roadmap and create opportunities for co-innovation in healthcare technologies
Subscribe To Our Newsletter & Stay Updated